Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

12.5%

1 terminated/withdrawn out of 8 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

67%

2 of 3 completed trials have results

Key Signals

3 recruiting2 with results

Enrollment Performance

Analytics

N/A
6(100.0%)
6Total
N/A(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT07061054Not ApplicableNot Yet Recruiting

Netrod-Pilot Study of Renal Denervation With NetrodTM Sixelectrode Radiofrequency RDN System

Role: collaborator

NCT06872567Not ApplicableRecruiting

Randomized Controlled Study Evaluating Genicular Artery Embolization Against Intra-Articular Corticosteroid Knee Injection for Osteoarthritic Knee Pain

Role: lead

NCT06188585Not ApplicableRecruiting

Randomized Trial of UI-EWD vs. Conventional Endoscopic Therapy for Nonvariceal Upper Gastrointestinal Bleeding

Role: collaborator

NCT04862156Not ApplicableTerminated

WP02 Continued Access Study

Role: collaborator

NCT04884542Recruiting

Multigen Plus H Study and AMF TT Cones

Role: collaborator

NCT05644132Not ApplicableCompleted

Thumb Hemi-Arthroplasty With Natural Kinematics (THANKS) Trial

Role: collaborator

NCT02775162Not ApplicableCompleted

WP01 - Normothermic Liver Preservation

Role: collaborator

NCT04136977Completed

XprESS ET Registry

Role: collaborator

All 8 trials loaded